Conclusion The current systematic review and meta- analysis showed that the long-term consumption of CLA increases the levels of CRP and Lp(a )
Background C-reactive protein ( CRP ) and lipoprotein ( a ) ( Lp[a ] ) play essential roles in cardiovascular disease incidence .
This study aim ed to review the association between the intake of conjugated linoleic acid ( CLA ) in the form of dietary supplement or enriched food with different treatment duration s and the levels of Lp(a ) and CRP in human studies .
Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.
Long-term supplementation with conjugated linoleic acid ( CLA ) reduces body fat mass ( BFM ) and increases or maintains lean body mass ( LBM ) . However , the regional effect of CLA was not studied . The study aim ed to evaluate the effect of CLA per region and safety in healthy , overweight and obese adults . A total of 118 subjects ( BMI : 28 - 32 kg/m2 ) were included in a double blind , placebo-controlled trial . Subjects were r and omised into two groups supplemented with either 3 x 4 g/d CLA or placebo for 6 months . CLA significantly decreased BFM at month 3 ( Delta=- 0 x 9 % , P=0 x 016 ) and at month 6 ( Delta=- 3 x 4 % , P=0 x 043 ) compared with placebo . The reduction in fat mass was located mostly in the legs ( Delta=- 0 x 8 kg , P<0 x 001 ) , and in women ( Delta=-1 x 3 kg , P=0 x 046 ) with BMI > 30 kg/m2 ( Delta=-1 x 9 kg , P=0 x 011 ) , compared with placebo . The waist-hip ratio decreased significantly ( P=0 x 043 ) compared with placebo .  LBM increased ( Delta=+0 x 5 kg , P=0 x 049 ) within the CLA group . Bone mineral content was not affected ( P=0 x 70 ) . All changes were independent of diet and physical exercise . Safety parameters including blood lipids , inflammatory and diabetogenic markers remained within the normal range . Adverse events did not differ between the groups . It is concluded that supplementation with CLA in healthy , overweight and obese adults decreases BFM in specific regions and is well tolerated
Conclusion The current systematic review and meta- analysis showed that the long-term consumption of CLA increases the levels of CRP and Lp(a )
Background C-reactive protein ( CRP ) and lipoprotein ( a ) ( Lp[a ] ) play essential roles in cardiovascular disease incidence .
This study aim ed to review the association between the intake of conjugated linoleic acid ( CLA ) in the form of dietary supplement or enriched food with different treatment duration s and the levels of Lp(a ) and CRP in human studies .